New Drugs for Old Cells – Oligonucleotide Senotherapeutics for Fibrotic Lung Diseases
Time: 11:50 am
day: Pre-Conference Seminar Day
Details:
- Highlighting how cellular senescence is a major contributor to ECM dysfunction, inflammation, and lung fibrosis
- Exploring how Dysregulated RNA processing is a new hallmark of ageing which drives senescence and can be drugged for rejuvenation of senescent cells
- Harnessing the power of oligonucleotide therapeutics to reprogram splicing regulation and restore function to aged primary human lung cells
